Search results for: Precision Medicine
Filter search results
Environmental sustainability in the NHS 10 Year Health Plan: The need for green
29 September 2025
…into electronic health records (EHRs) and clinical guidelines (e.g., flagging low-carbon treatment options using tools like the Medicine Carbon Footprint Formulary) Develop and mandate carbon impact assessments for all clinical…
Spotlight on OHE: Opportunity Costs of NICE Decisions in Wales and HESG 2015
20 January 2015
…in the OHE research paper with the same title [OHE Research paper 14/02]. This presentation was part of the “Medicines Knowledge Base” series of lunchtime briefing seminars organised by…
OHE Occasional Paper Critiques the Claxton et al. £13,000 per QALY Estimate
24 February 2015
…life year (QALY) in the English NHS in 2008/09. NICE currently uses a cost per QALY threshold of £20,000 to £30,000 – and so recommends many medicines and other…
OHE Briefing on Incentives to Follow Best Practice in Health Care
27 February 2015
…medicines or other health technologies. These incentives include monetary and non-monetary rewards. In the first section of the Briefing, the authors report the results of a review of empirical…
Do Respondents Completing Abstract, Hypothetical Priority-Setting Exercises Agree with the Policy Implications of Their Choices?
3 March 2015
…of life: A stated preference discrete choice experiment. Social Science & Medicine, 124, pp.48-56. [available to download free-of-charge] For additional information about this study, please contact Koonal Shah. …
A Framework for Payer Assessment of the Value of New Technologies: A US Approach
10 March 2015
…is a Lecturer in the Department of Population Medicine at Harvard Medical School and has served as Special Advisor, Technology and Coverage Policy, within the Coverage and Analysis Group at…
Legal Barriers to the Better Use of Health Data to Deliver Pharmaceutical Innovation
1 December 2018
…key activities across the lifecycle of a medicine: Epidemiology and pharmacoepidemiology: Identifying unmet need; Pharmacogenetics; Interventional studies; Non-interventional studies; Pharmacovigilance, and; Managed entry agreements. We conclude that the GDPR does…
Health Care as a Handicraft Industry
9 January 1995
…a doctor or obtaining a prescription medicine. Of course this perspective reflects, in part, what is achievable in designing a health care system in the US. His views on the…
Opportunities for Utilising ‘Real World Data’ in South Korea
20 October 2017
OHE publishes a report assessing the capacity in South Korea for the collection and use of real-world data in health care. Real world data (RWD) is information collected from a…